SomaLogic Garners $60,500,000 New Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    2945 Wilderness Place Boulder, CO 80301 USA
  • Company Description
    SomaLogic, Inc. is developing novel proteomics systems and applications based on its proprietary aptamer technology. Aptamers are single-stranded DNA and RNA molecules that, like antibodies, can bind to target molecules with high affinity and specificity.
  • Website
  • Transaction Type
    Venture Equity, Debt
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    The proceeds will be used to support SomaLogic’s continued growth, including its primary focus on the development of novel life science tools and clinical diagnostics based on the Company’s proprietary proteomics technology.
  • M&A Terms
  • Venture Investor

Trending on Xconomy